Dr Alvin Lee MA PhD FRCP (Glasg) FRSB is a consultant medical oncologist specialising in melanoma and lung cancers. He performs research at the Francis Crick Institute.

He graduated from the University College London MB PhD programme. He obtained the ESMO Examination certification and has postgraduate certificates in genomic medicine, medical education, oncology, and clinical research.

GMC number


A Multicentric, Retrospective, Real-world Study on Immune-related Adverse Events in Patients with Advanced Non-small Cell Lung Cancers Treated with Pembrolizumab Monotherapy 

Clinical Oncology 2024 


Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer 

Journal of Clinical Oncology 2023 


COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic. 

British Journal of Cancer 2021 


COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study 

The Lancet 2020 


CERT depletion predicts chemotherapy benefit and mediates cytotoxic and polyploid-specific cancer cell death through autophagy induction 

The Journal of Pathology 2012 


Chromosomal Instability Confers Intrinsic Multidrug Resistance 

Cancer Research 2011